Inovio Pharmaceuticals
INO
#8857
Rank
C$0.20 B
Marketcap
C$3.00
Share price
-0.46%
Change (1 day)
-47.51%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -C$0.16 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are C$0.18 Million. In 2024 the company made an earning of -C$0.15 Billion, an increase over its 2023 earnings that were of -C$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.16 Billion2.4%
2024 -C$0.15 Billion-20.03%
2023 -C$0.19 Billion-51.56%
2022 -C$0.39 Billion-8.26%
2021 -C$0.42 Billion95.4%
2020 -C$0.22 Billion36.62%
2019 -C$0.16 Billion20.19%
2018 -C$0.13 Billion10.94%
2017 -C$0.12 Billion9.59%
2016 -C$0.11 Billion118.9%
2015 -C$48.76 Million-10.67%
2014 -C$54.58 Million83.32%
2013 -C$29.77 Million
2011 -C$30.72 Million15.64%
2010 -C$26.56 Million37.7%
2009 -C$19.29 Million2.19%
2008 -C$18.88 Million-14.09%
2007 -C$21.97 Million19.12%
2006 -C$18.45 Million9.62%
2005 -C$16.83 Million5.77%
2004 -C$15.91 Million73.08%
2003 -C$9.19 Million12.75%
2002 -C$8.16 Million
2000 -C$12.34 Million53.93%
1999 -C$8.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$16.37 B-11,064.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.76 B-30,070.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-C$0.11 Billion-30.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.68 B-15,289.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$31.90 B-21,461.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$12.88 B-8,724.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
C$13.66 B-9,245.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-C$3.81 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA